Health
Inhaled CRISPR Treatment Targets Influenza and SARS-CoV-2 Infections – Genetic Engineering & Biotechnology News
The treatment uses a type of CRISPR to target viral RNA and appears to stop replication of both viruses in the lungs.
If you think breathing in gene editing enzymes to treat infectious diseases, such as the flu or COVID-19, is a technology that is far-fetched or a long way off, think again. A team of investigators from the Georgia Institute of Technology and Emory University has developed a CRISPR-based treatment to stop the replication of both the flu virus and the virus that causes COVID-19 in mice. Moreover, the new treatment is delivered to the lungs via a nebulizer, which could make it simple for patients…
-
Noosa News23 hours agoPill checking to resume in Queensland months after government axed funding
-
Noosa News21 hours agoQueensland girl Millie’s fight for life after magnets tore through her bowel
-
Noosa News11 hours agoSee inside the hidden suburbs where Queensland investors really live
-
Noosa News21 hours agoMother who faked daughter’s medical conditions, forged documents, granted immediate parole